AKERO THERAPEUTICS INC shareholders Q3 2023

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JPMORGAN CHASE & CO 714,578$36,143,3550.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 350,909$17,748,9770.00%
Banque Cantonale Vaudoise 1,000$510.00%
SOA Wealth Advisors, LLC. 203$10,2680.00%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 12,000$606,9600.00%
Mirae Asset Global Investments Co., Ltd. 30,318$1,533,4840.00%
JANE STREET GROUP, LLC 176,036$8,903,9000.00%
QUADRANT CAPITAL GROUP LLC 611$30,9050.00%
GOLDMAN SACHS GROUP INC 331,085$16,746,2800.00%
Invesco Ltd. 252,553$12,774,1310.00%
AMALGAMATED BANK 7,559$3820.00%
Handelsbanken Fonder AB 9,500$4810.00%
Citadel Advisors 302,587$15,304,8510.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 301,700$15,259,9860.00%
GTS SECURITIES LLC 28,200$1,426,3560.00%
SIGNATUREFD, LLC 1,990$100,6540.00%
DekaBank Deutsche Girozentrale 27,600$1,3320.00%
Newbridge Financial Services Group, Inc. 65$3,2880.00%
NEW YORK STATE COMMON RETIREMENT FUND 33,331$1,6860.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 76,613$3,875,0860.00%
External links

This page lists AKERO THERAPEUTICS INC's shareholders in Q3 2023. To view AKERO THERAPEUTICS INC's shareholder history, click here.